Look at the insider selling last week. What are you talking about, management sells ALL of their options shares every quarter. I never see any open market buying -- never.
Singular research put out a buy recommendation last June 8 with a 12-month target price of $23/shr. This estimate was not even in the same league, let alone ball park. They need to update their estimate and disclose their revised estimate with an explanation for the shortfall. Analysts don't simply put out a projection for their 12-month price target, and leave them in place for however many years it takes for that target to be reached; they review their suggestions within the year and update them with a footnote of what has transpired. In this case they were overzealous with their outlook for ongoing financials, looking for unattainable revenue and earnings numbers, while gross and operating margins did not increase.
The 4th Quarter financial report, which is historically the strongest quarter included the revenues and earnings from the 2 acquisitions. RITEC was pricey at around $8M. The T&M report was in line with past quarters that did not include these two supposedly accretive acquisitions. Where is the contribution from them? Even with delayed orders, the top line should have increased accordingly with a larger customer base. No analyst thought to inquire about this issue.
Following the anticipated earnings miss, the pps is slowly retreating back to its norm where it belongs. Somebody raised an inordinate amount of hoopla with no basis, and bumped it up to 15 for a few days. With a tailwind, fair value is around $12.00. This earnings announcement did not have lots of positives, the company's financials are still stuck in Quicksand. Growth is too slow to justify higher stock prices.
They cannibalized the successful touch screen Vivo label printer with these newer models. What happened to the Vivo, which was the core of their successful printer line?
Yes, prices are always based on expectations for any company. This one, like all others has all potential positives priced into the shs. Historical earnings reports also contained many positives, many of which never materialized or came to pass. They need revenue to grow faster than 10% for growth to make it to the bottom line, and there is always an excuse, most every quarterly report for past financial shortfalls.
Selling the profitable "Grass" neurological product division did not make sense, and it was never explained why they did that; the company doesn't need the cash.
Stocks trade on future earnings. Read the earnings announcement, lots of positives. Also, this company has a lot of recurring (sticky) revenues from consumables and for the first time in company history they are manufacturing their ink and other consumables with 3 shifts, or 24 hours per day. It would be higher if it wasn't so thinly traded. I don't see any insiders selling either.
With a historical P/E of around 20 times past earnings, these shares are currently around 20% overpriced. With growth barely hitting double digits, there is not enough excitement to trade the shares much higher. Gross margins are struggling to maintain past levels, yet it's said over and over that the margins are expanding. Who is fooling who here?